On September 2nd, Zhejiang Tianyuan Biotechnology Co., Ltd. successfully held a lecture on the theme of "Application of Laboratory Projects in the Market" at its headquarters. This lecture specially invited Director Yao Jincheng, the head of Tianxuan Biological Laboratory, as the keynote speaker, attracting numerous professionals from the medical, scientific research, and industrial fields to participate.

     Director Yao Jincheng explained in detail several core laboratory testing projects of Zhejiang Tianyuan Biotechnology Co., Ltd. during the lecture, including a series of testing projects such as immunity, heart and brain infarction, DR70, and ctDNA. These projects represent the latest advances in biotechnology in disease diagnosis and health management.

     The immune testing program is an important tool for evaluating an individual's immune status, which comprehensively assesses the body's immune level through a series of biochemical and cytological indicators. Director Yao Jincheng emphasized that immune testing is of great significance for early detection of disease risks, monitoring disease progression, and evaluating treatment effectiveness.

     The DR70 detection project, as a novel tumor biomarker, has attracted high attention from attendees due to its high sensitivity and broad application prospects. Director Yao Jincheng pointed out that DR70 testing has shown great potential in the early diagnosis of various high-risk cancers, which can help improve the early detection rate and survival rate of patients.

     During the lecture, the audience actively participated in the interaction and raised questions about the technical details, market prospects, and application cases of the testing project. Director Yao Jincheng provided in-depth answers and discussions to the audience with his rich professional knowledge and practical experience.

     This lecture not only showcased the research and development capabilities of Zhejiang Tianyuan Biotechnology Co., Ltd. in the field of biotechnology, but also strengthened the participants' understanding of the importance of laboratory testing projects in practical applications. The company stated that it will continue to promote the market conversion of these projects and contribute to improving public health